Notably, in patients with relapsing-remitting MS (RRMS), CSF CXCL13 levels are associated with increased relapse rate and disease severity measured by the expanded disability status scale (EDSS) (129). This evidence concerns the gene CXCL13 and relapsing-remitting multiple sclerosis.